Hypokalaemic Metabolic Alkalosis, Hypertension and Diabetes: What is the Link

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2019 Jan 21

PMID 30661045

Authors

Marius Vogelin

Richard Cathomas

Niklaus Kamber

Thomas Fehr

Affiliations

Soon will be listed here.

Abstract

Two years after diagnosis of a metastatic neuroendocrine gastrin-secreting tumour and after several cycles of chemotherapy and peptide receptor radionuclide therapy, a 56-year-old woman presented with hypokalaemic metabolic alkalosis, hypertension, leg oedema and new-onset diabetes mellitus. Further investigations revealed renal potassium loss confirmed by a transtubular potassium gradient of 16, fully suppressed serum aldosterone, but instead highly elevated blood levels of morning cortisol and adrenocorticotropic hormone as well as increased urinary excretion of glucocorticoid and mineralocorticoid metabolites. Ruling out other causes, paraneoplastic hypercortisolism was diagnosed. Pharmacological inhibition of the steroid 11β-hydroxylase with metyrapone resulted in complete resolution of metabolic alkalosis, hypokalaemia, hypertension, hyperglycaemia and leg oedema within 1 week.

References

Daniel E, Newell-Price J . Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome. Eur J Endocrinol. 2015; 172(6):R263-80. DOI: 10.1530/EJE-14-1014. View

Maiter D, Bex M, Vroonen L, TSjoen G, Gil T, Banh C . Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients. Ann Endocrinol (Paris). 2016; 77(5):578-585. DOI: 10.1016/j.ando.2016.02.005. View

Deldycke A, Haenebalcke C, Taes Y . Paraneoplastic Cushing syndrome, case-series and review of the literature. Acta Clin Belg. 2017; 73(4):298-304. DOI: 10.1080/17843286.2017.1373927. View

Aron D, Raff H, Findling J . Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1997; 82(6):1780-5. DOI: 10.1210/jcem.82.6.3991. View

Young J, Deneux C, Grino M, Oliver C, Chanson P, Schaison G . Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion. J Clin Endocrinol Metab. 1998; 83(2):305-8. DOI: 10.1210/jcem.83.2.4549. View

Zarate A, Kovacs K, Flores M, Moran C, Felix I . ACTH and CRF-producing bronchial carcinoid associated with Cushing's syndrome. Clin Endocrinol (Oxf). 1986; 24(5):523-9. DOI: 10.1111/j.1365-2265.1986.tb03281.x. View

. Nizoral (Ketoconazole): drug safety communication- potentially fatal liver injury, risk of drug interactions, and adrenal gland problems. Clin Infect Dis. 2013; 57(8):i. View

Park S, Rhee Y, Youn J, Park Y, Lee S, Kim D . Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma. Exp Clin Endocrinol Diabetes. 2007; 115(1):13-6. DOI: 10.1055/s-2007-948212. View

LIDDLE G, ISLAND D, NEY R, NICHOLSON W, Shimizu N . Nonpituitary neoplasms and Cushing's syndrome. Ectopic "adrenocorticotropin" produced by nonpituitary neoplasms as a cause of Cushing's syndrome. Arch Intern Med. 1963; 111:471-5. DOI: 10.1001/archinte.1963.03620280071011. View

10.

Khare J, Daga S, Nalla S, Deb P . Ectopic adrenocorticotropic hormone syndrome in a case of duodenal neuroendocrine tumor presenting with liver metastasis. J Postgrad Med. 2017; 64(1):47-49. PMC: 5820814. DOI: 10.4103/jpgm.JPGM_772_16. View

11.

Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F . Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab. 1999; 84(2):440-8. DOI: 10.1210/jcem.84.2.5465. View

12.

Ilias I, Torpy D, Pacak K, Mullen N, Wesley R, Nieman L . Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005; 90(8):4955-62. DOI: 10.1210/jc.2004-2527. View

13.

Utz A, Biller B . The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol. 2008; 51(8):1329-38. DOI: 10.1590/s0004-27302007000800019. View

14.

Russo M, Scollo C, Pellegriti G, Cotta O, Squatrito S, Frasca F . Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clin Endocrinol (Oxf). 2015; 84(4):614-9. DOI: 10.1111/cen.12868. View

15.

Gut P, Waligorska-Stachura J, Czarnywojtek A, Sawicka-Gutaj N, Baczyk M, Ziemnicka K . Management of the hormonal syndrome of neuroendocrine tumors. Arch Med Sci. 2017; 13(3):515-524. PMC: 5420621. DOI: 10.5114/aoms.2016.60311. View

16.

Schteingart D, Lloyd R, Akil H, Chandler W, Rosen S, Ogletree R . Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab. 1986; 63(3):770-5. DOI: 10.1210/jcem-63-3-770. View

17.

Shahani S, Nudelman R, Nalini R, Kim H, Samson S . Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol. 2010; 5:56. PMC: 2942804. DOI: 10.1186/1746-1596-5-56. View

18.

Karageorgiadis A, Papadakis G, Biro J, Keil M, Lyssikatos C, Quezado M . Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab. 2014; 100(1):141-8. PMC: 4283025. DOI: 10.1210/jc.2014-2945. View

19.

Hahner S, Fassnacht M . Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs. 2005; 6(4):386-94. View

20.

Verhelst J, Trainer P, Howlett T, Perry L, Rees L, Grossman A . Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf). 1991; 35(2):169-78. DOI: 10.1111/j.1365-2265.1991.tb03517.x. View